ALMR Alamar Biosciences, Inc.
Alamar Biosciences, Inc. (ALMR) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is a loss of $0.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.0% since its last earnings release on November 3, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Alamar Biosciences, Inc.
Alamar is a commercial-stage proteomics company establishing a gold standard in protein detection and analysis.
Sector
Healthcare
Industry
Medical Instruments/Supply
Charts powered in part by Lightweight Charts™ by TradingView.